Cargando…

Evaluation of extension of breast screening to women aged 65–70 in England using screening performance measures

The objective of this study was to investigate screening performance measures in the English screening units that began inviting women aged 65–70 between 1 April 2001 and 1 April 2004. We analysed results after each unit commenced inviting women aged 65–70. In addition, we analysed data from units t...

Descripción completa

Detalles Bibliográficos
Autores principales: Bennett, R L, Blanks, R G, Moss, S M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2669999/
https://www.ncbi.nlm.nih.gov/pubmed/19277039
http://dx.doi.org/10.1038/sj.bjc.6604981
_version_ 1782166293015691264
author Bennett, R L
Blanks, R G
Moss, S M
author_facet Bennett, R L
Blanks, R G
Moss, S M
author_sort Bennett, R L
collection PubMed
description The objective of this study was to investigate screening performance measures in the English screening units that began inviting women aged 65–70 between 1 April 2001 and 1 April 2004. We analysed results after each unit commenced inviting women aged 65–70. In addition, we analysed data from units that invited this age group for a second time between 1 April 2004 and 31 March 2007. Results for women aged 65–70 were compared to women aged 50–64 and 60–64. Average uptake was 72.8% for women aged 65–70 and 76.7% for women aged 50–64. For women screened within the last 5 years, uptake was 88.7% for older women and 89.1% for younger women. For women previously screened within 5 years the invasive cancer detection rate was 17% higher in the 65–70 age group than in the 60–64 age group. The rates of recall to assessment and PPV were 3.5 and 27.6% in women aged 65–70 and 3.4 and 24.6% in women aged 50–64 respectively. These results suggest that, as in the earlier demonstration studies, uptake rates remain high in older women, and many more older women attend following an invitation than had previously self-referred. The cancer detection rate is higher in this older age group, whereas rates of recall are generally similar to those in younger women; consequently the PPV is also higher in older women.
format Text
id pubmed-2669999
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-26699992010-04-07 Evaluation of extension of breast screening to women aged 65–70 in England using screening performance measures Bennett, R L Blanks, R G Moss, S M Br J Cancer Clinical Study The objective of this study was to investigate screening performance measures in the English screening units that began inviting women aged 65–70 between 1 April 2001 and 1 April 2004. We analysed results after each unit commenced inviting women aged 65–70. In addition, we analysed data from units that invited this age group for a second time between 1 April 2004 and 31 March 2007. Results for women aged 65–70 were compared to women aged 50–64 and 60–64. Average uptake was 72.8% for women aged 65–70 and 76.7% for women aged 50–64. For women screened within the last 5 years, uptake was 88.7% for older women and 89.1% for younger women. For women previously screened within 5 years the invasive cancer detection rate was 17% higher in the 65–70 age group than in the 60–64 age group. The rates of recall to assessment and PPV were 3.5 and 27.6% in women aged 65–70 and 3.4 and 24.6% in women aged 50–64 respectively. These results suggest that, as in the earlier demonstration studies, uptake rates remain high in older women, and many more older women attend following an invitation than had previously self-referred. The cancer detection rate is higher in this older age group, whereas rates of recall are generally similar to those in younger women; consequently the PPV is also higher in older women. Nature Publishing Group 2009-04-07 2009-03-10 /pmc/articles/PMC2669999/ /pubmed/19277039 http://dx.doi.org/10.1038/sj.bjc.6604981 Text en Copyright © 2009 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Clinical Study
Bennett, R L
Blanks, R G
Moss, S M
Evaluation of extension of breast screening to women aged 65–70 in England using screening performance measures
title Evaluation of extension of breast screening to women aged 65–70 in England using screening performance measures
title_full Evaluation of extension of breast screening to women aged 65–70 in England using screening performance measures
title_fullStr Evaluation of extension of breast screening to women aged 65–70 in England using screening performance measures
title_full_unstemmed Evaluation of extension of breast screening to women aged 65–70 in England using screening performance measures
title_short Evaluation of extension of breast screening to women aged 65–70 in England using screening performance measures
title_sort evaluation of extension of breast screening to women aged 65–70 in england using screening performance measures
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2669999/
https://www.ncbi.nlm.nih.gov/pubmed/19277039
http://dx.doi.org/10.1038/sj.bjc.6604981
work_keys_str_mv AT bennettrl evaluationofextensionofbreastscreeningtowomenaged6570inenglandusingscreeningperformancemeasures
AT blanksrg evaluationofextensionofbreastscreeningtowomenaged6570inenglandusingscreeningperformancemeasures
AT mosssm evaluationofextensionofbreastscreeningtowomenaged6570inenglandusingscreeningperformancemeasures